콘텐츠로 건너뛰기
Merck

다음으로 건너뛰기

A1393

Sigma-Aldrich

5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranosyl 5′-monophosphate

≥93%

동의어(들):

AICAR monophosphate, N1-(β-D-5′-Phosphoribofuranosyl)-5-aminoimidazole-4-carboxamide, NSC 283955, NSC 292227, ZMP

로그인조직 및 계약 가격 보기

크기 선택

1 G
MYR 276.00

MYR 276.00


장바구니에서 구매 가능 여부 확인하기

크기 선택

보기 변경
1 G
MYR 276.00

About This Item

실험식(Hill 표기법):
C9H15N4O8P
CAS Number:
Molecular Weight:
338.21
EC Number:
MDL number:
UNSPSC 코드:
41106305
PubChem Substance ID:
NACRES:
NA.51

MYR 276.00


장바구니에서 구매 가능 여부 확인하기

기술 서비스
도움이 필요하신가요? 저희 숙련된 과학자 팀이 도와드리겠습니다.
도움 문의

Quality Level

분석

≥93%

양식

powder

분자량

338.21  g/mol

저장 온도

−20°C

SMILES string

O[C@H]1[C@@H](O)[C@H](N2C=NC(C(N)=O)=C2N)O[C@@H]1COP(O)(O)=O

InChI

1S/C9H15N4O8P/c10-7-4(8(11)16)12-2-13(7)9-6(15)5(14)3(21-9)1-20-22(17,18)19/h2-3,5-6,9,14-15H,1,10H2,(H2,11,16)(H2,17,18,19)/t3-,5-,6-,9-/m1/s1

InChI key

NOTGFIUVDGNKRI-UUOKFMHZSA-N

유사한 제품을 찾으십니까? 방문 제품 비교 안내

관련 카테고리

유사한 품목 비교

전체 비교 보기

차이점 표시

1 of 4

이 품목
H1038C8739A6861
Hck human recombinant, expressed in E. coli BL21, vial of ≥200 units

H1038

Hck human

specific activity

≥1400 unit/μg protein

specific activity

1-2 unit/μg protein

specific activity

50-100 units/μg protein

specific activity

≥25 units/μg protein

form

solution

form

solution

form

solution

form

solution

recombinant

expressed in E. coli

recombinant

expressed in E. coli BL21

recombinant

expressed in E. coli BL21

recombinant

expressed in Sf9 cells

storage temp.

−70°C

storage temp.

−70°C

storage temp.

−70°C

storage temp.

−70°C

shipped in

dry ice

shipped in

dry ice

shipped in

dry ice

shipped in

dry ice

mol wt

42 kDa

mol wt

-

mol wt

-

mol wt

-

일반 설명

5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranosyl 5′-monophosphate (AICAR), a natural metabolic intermediate of purine biosynthesis, is usually found in all organisms. It is produced from succinyl-AICAR (SAICAR) with the help of adenylosuccinate lyase (ASL) enzyme.[1]

애플리케이션

5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranosyl 5′-monophosphate has been used in the study to explore the anticancer effect of nine statins in breast cancer and glioblastoma.[2]
AICAR monophosphate is a 5′′-phosphorylated analog of cell permeable AICAR that mimics AMP. AICAR is an adenosine monophophate (AMP)-activated protein kinase (AMPK) activator/agonist.

생화학적/생리학적 작용

A 5′-phosphorylated analog of cell permeable AICAR that mimics adenosine monophosphate (AMP). It is an AMP-activated protein kinase (AMPK) activator.
In humans, 5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranosyl 5′-monophosphate (AICAR) is found to be accumulated in numerous metabolic diseases. It can increase the endurance of sedentary mice. AICAR exhibits antiproliferative effects. It can induce apoptosis of aneuploid cells.[1]

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point (°F)

Not applicable

Flash Point (°C)

Not applicable

개인 보호 장비

Eyeshields, Gloves, type N95 (US)


  • 가장 최신 버전 중 하나를 선택하세요:

    시험 성적서(COA)

    Lot/Batch Number

    적합한 버전을 찾을 수 없으신가요?

    특정 버전이 필요한 경우 로트 번호나 배치 번호로 특정 인증서를 찾을 수 있습니다.

    이 제품을 이미 가지고 계십니까?

    문서 라이브러리에서 최근에 구매한 제품에 대한 문서를 찾아보세요.

    문서 라이브러리 방문

    Oral Strip Technology: A review
    Jaiswal, Hema
    Indian Journal of Pharmaceutical and Biological Research, 2(2), 130-130 (2014)
    Ethylcellulose--A Pharmaceutical Excipient with Multidirectional Application in Drug Dosage Forms Development
    Wasilewska K and Winnicka K
    Materials, 12(20), 3386-3386 (2019)
    Detection and quantification of low-molecular-weight aldehydes in pharmaceutical excipients by headspace gas chromatography
    Li Z, et al.
    Journal of Chromatography A, 1104(1-2), 1-10 (2006)
    Development and validation of a gradient HPLC method for the determination of clindamycin and related compounds in a novel tablet formulation.
    Platzer DJ, White BA.
    Journal of Pharmaceutical and Biomedical Analysis, 41(1), 84-88 (2006)
    M R Abbaspour et al.
    European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 68(3), 747-759 (2007-11-06)
    One challenge in tableting of sustained-release multiparticulates is maintaining the desired drug release after compaction. The aim of this study was to design sustained-release ibuprofen tablets which upon oral ingestion rapidly disintegrate into sustained-release pellets in which the integrity of

    자사의 과학자팀은 생명 과학, 재료 과학, 화학 합성, 크로마토그래피, 분석 및 기타 많은 영역을 포함한 모든 과학 분야에 경험이 있습니다..

    고객지원팀으로 연락바랍니다.